US Patent Issued to Celltaxis on Feb. 24 for "Method of reducing pulmonary exacerbations in respiratory disease patients" (Florida, Georgia, Indiana Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,353, issued on Feb. 24, was assigned to Celltaxis LLC (Atlanta).

"Method of reducing pulmonary exacerbations in respiratory disease patients" was invented by Sanjeev Ahuja (Carmel, Ind.), Ralph Grosswald (Alpharetta, Ga.), Gregory S. Duncan (Atlanta) and Eric B. Springman (Punta Gorda, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described are methods of reducing pulmonary exacerbations and methods of treating cystic fibrosis, including methods of reducing pulmonary inflammation, comprising administration of an LTA4h inhibitor."

The patent was filed on Dec. 20, 2023, under Application No. 18/390,000.

*For further information, including imag...